The Global Health Body Sounds Warning Over Acute Scarcity of Obesity Injections

Less than one in 10 patients who could benefit from obesity jabs such as Wegovy are able to get them, warns the global health agency as it releases its inaugural advice on the medications.

Considering more than one billion individuals worldwide currently classified as obese, it is advocating for more widespread and fairer availability to GLP-1 medication.

Per estimates, in excess of 2,000,000,000 could be living with obesity by 2030 unless action is taken.

"Our latest guidance affirms that excess weight is a chronic disease that can be treated with holistic and lifelong treatment," said WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and distribution challenges are significant obstacles to broad availability to the treatments that can assist patients in reducing substantial body mass, says the organization.

Skinny Jab Scarcity

Despite the current most favorable outlook, the supply of such drugs could only cover around 100 million people – less than 10% of eligible patients, according to the WHO.

The recommendation urges countries and companies to expand access, by approaches such as licensing agreements.

Exclusive production rights on a key compound – the main ingredient of the drug Wegovy – is set to lapse in a number of countries in 2026.

How Weight-Loss Jabs Function

The injections imitate a natural hormone to reduce digestion speed, suppress the appetite and boost feelings of fullness so people eat less.

People usually see weight reduction in the initial weeks of commencing the once-weekly jabs.

Studies suggests people may regain a significant portion a year later of halting the medication, because their usual hunger return.

Being above a healthy weight increases your likelihood for experiencing diseases, like type 2 diabetes, cardiovascular issues, brain attack, and specific cancers.

Obesity impacts individuals in countries worldwide and was associated with millions of fatalities worldwide in 2024, according to the WHO.